Myostatin-inhibiting antibodies increase muscle mass in animals by blocking biological signals that normally restrict muscle growth.
From The Ultimate Peptide Stack? Gain Muscle, Lose Fat! · videoSee the scientific wording
Myostatin-inhibiting antibodies increase muscle mass in preclinical models by directly blocking signaling pathways that limit muscle growth.
Very strong evidence
Mixed evidence6 high-quality studies support this claim.
What the research says
6 studies reviewedSupporting (6)
Randomized Controlled TrialHuman2025
Scientists gave people special antibodies that block a protein (myostatin) that normally stops muscles from growing. The result? People’s thigh muscles got about 6% bigger while they were taking the treatment — proving that blocking myostatin really does make muscles grow.
Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
Randomized Controlled TrialAnimal2018
Scientists gave mice a special antibody that stops a protein called myostatin from telling muscles to stop growing. The mice’s muscles got 17.5% bigger and stronger, without getting weaker — proving the antibody works like it’s supposed to.
Cohort StudyAnimal2016
Scientists gave mice a special antibody that blocks a signal telling muscles to stop growing. The mice got stronger and their muscles got bigger, proving the antibody works like a 'stop sign' remover for muscle growth.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
A protein called myostatin normally stops muscles from growing by sending a signal through receptors on muscle cells. When antibodies block myostatin, this signal cannot be sent, so the muscle cells stop breaking down proteins and start building more muscle fibers, making the muscles larger and stronger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 6 supporting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Myostatin-inhibiting antibodies increase muscle mass in animals by blocking biological signals that normally restrict muscle growth.
Mechanism
6 studiesMyostatin is a natural brake on muscle growth. Antibodies that block myostatin remove this brake, so muscle cells stop breaking down proteins and start building more muscle fibers. This makes muscles larger and stronger without changing how they work.
A protein called myostatin normally stops muscles from growing by sending a signal through receptors on muscle cells. When antibodies block myostatin, this signal cannot be sent, so the muscle cells stop breaking down proteins and start building more muscle fibers, making the muscles larger and stronger.
Myostatin exists in the extracellular space as an inactive precursor bound to a prodomain, and requires proteolytic cleavage to become active.
Antibodies bind to myostatin in its precursor, latent, or mature forms, preventing its cleavage or receptor binding.
Blocking myostatin prevents its interaction with the ActRIIB receptor on skeletal muscle cells.
Inhibition of ActRIIB signaling reduces phosphorylation of SMAD2 and SMAD3 transcription factors.
Reduced SMAD2/3 signaling decreases expression of atrophy-related genes such as MuRF1 and Atrogin-1 and removes suppression of muscle protein synthesis.
Muscle cells increase protein accretion and fiber cross-sectional area, resulting in greater muscle mass and force production.
Evidence from Studies
Last searched 2mo ago
Supporting (6)
Community contributions welcome
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial
Scientists gave people special antibodies that block a protein (myostatin) that normally stops muscles from growing. The result? People’s thigh muscles got about 6% bigger while they were taking the treatment — proving that blocking myostatin really does make muscles grow.
Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
Scientists gave mice a special antibody that stops a protein called myostatin from telling muscles to stop growing. The mice’s muscles got 17.5% bigger and stronger, without getting weaker — proving the antibody works like it’s supposed to.
Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice
Scientists gave mice a special antibody that blocks a signal telling muscles to stop growing. The mice got stronger and their muscles got bigger, proving the antibody works like a 'stop sign' remover for muscle growth.
ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus)
This study gave monkeys a drug that blocks a natural signal that stops muscles from growing, and their muscles got bigger and stronger — just like the claim says.
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
This study gave mice a special antibody that blocks a natural 'stop signal' for muscle growth, and their muscles got bigger and stronger — proving the idea works in animals.
Scientists used a special drug that blocks a natural brake on muscle growth, and in mice and monkeys, muscles got significantly bigger — proving that stopping this brake helps muscles grow.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Myostatin-Inhibiting Antibodies on Muscle Mass in Preclinical Animal Models
Population: Multiple animal models (e.g., mice, rats) with induced muscle atrophy; Intervention: Myostatin-inhibiting antibodies; Comparator: Placebo or isotype control; Outcome: Muscle mass change measured by wet weight or imaging; Duration: 4–12 weeks across included studies.
Randomized Double-Blind Trial of Myostatin-Inhibiting Antibody vs Placebo in Rodents for Muscle Mass Gain
Population: Healthy adult rodents; Intervention: Single dose or repeated dosing of myostatin-inhibiting antibody; Comparator: Saline or non-targeting IgG; Outcome: Quadriceps muscle mass measured post-treatment; Duration: 6 weeks.
Longitudinal Cohort of Rodents Treated with Myostatin-Inhibiting Antibodies and Muscle Mass Trajectories
Population: Cohort of rodents receiving myostatin-inhibiting antibodies; Comparator: Cohort receiving no intervention; Outcome: Serial measurements of muscle mass over 8 weeks; Duration: 8 weeks.
In Vitro Analysis of Myostatin-Inhibiting Antibodies on Skeletal Muscle Cell Proliferation and Differentiation
Population: Primary myoblasts or C2C12 cell lines; Intervention: Exposure to myostatin-inhibiting antibody; Comparator: Control antibody or vehicle; Outcome: Myotube formation, myosin expression, and pathway inhibition markers; Duration: 72 hours.
Single-Arm Preclinical Study of Myostatin-Inhibiting Antibody on Muscle Mass in Mice
Population: C57BL/6 mice; Intervention: Single intraperitoneal injection of myostatin-inhibiting antibody; Comparator: None; Outcome: Tibialis anterior muscle mass at day 14; Duration: 14 days.